48 Results for "

CA XII

" in MedChemExpress (MCE) Product Catalog:
Products (48)

48 Results for "CA XII" in MCE Product Catalog:

8
8 Publications Verification
Cat. No.: HY-13513
CAS No.: 178606-66-1
Purity:  99.95%
Synonyms: SLC-0111
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

U-104 (SLC-0111) is a potent carbonic anhydrase (CA) inhibitor for CA IX and CA XII with Ki values of 45.1 nM and 4.5 nM, respectively. U-104 shows a significant delay in tumor growth in mice model .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-110243
CAS No.: 1330061-67-0
Purity:  99.04%
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

CAIX Inhibitor S4 is a potent and selective inhibitor of carbonic anhydrase IX/XII (CA IX/XII), with a Ki of 7 nM and 2 nM, respectively. CAIX Inhibitor S4 also inhibits CA II and CA I (Ki=546 and 5600 nM, respectively). CAIX Inhibitor S4 can inhibit the number of lung metastasis in orthotopic MDA-MB-231 mouse model without affecting primary tumor growth .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72866
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CA12; CDNA FLJ20151 Fis, Clone COL08412; CArbonic Anhydrase 12; CArbonic Dehydratase; CArbonic Anhydrase XII; CArbonic Anhydrase; HsT18816; CA12 Protein; Tumor Antigen HOM-RCC-3.1.3; T18816; CArbonate Dehydratase XII; CAXII; CA-XII
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-151917
CAS No.: 2883495-39-2
Purity:  99.76%
Enpp/Carbonic anhydrase-IN-2 (compound 1i) is a potent Enpp and carbonic anhydrase inhibitor with IC50s of 1.13, 1.07, 0.74, 0.33, 0.68 for NPP1, NPP2, NPP3, CA-IX, CA-XII respectively. Enpp/Carbonic anhydrase-IN-2 shows antiproliferative activity for cancer cells and low cytotoxic against normal cells. Enpp/Carbonic anhydrase-IN-2 induces Apoptosis .
loading...
    loading...
Cat. No.: HY-76779
CAS No.: 25392-41-0
Target:  

Drug Derivative

Research Areas:  

Cancer

4-(Chloromethyl)-7-hydroxycoumarin (compound 4) is a hydroxycoumarin derivative with potent antioxidant effect and high hydroxyl radical-scavenging property. 4-(Chloromethyl)-7-hydroxycoumarin contains a methyl group and a chlorine group in the heterocyclic ring. A series of coumarins incorporating hydroxy-, chloro- and/or chloromethyl-moieties has been investigated as potent inhibitors of the zinc enzyme carbonic anhydrase, expecially tumor-associated isoforms CA IX and XII .
loading...
    loading...
Cat. No.: HY-146819
CAS No.: 2439165-37-2
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

Compound 9 is the most effective against tumor specific Ca ix/ca XII (ki=29.1 and 8.8 nm), so it is possible to evaluate its cytotoxicity and selectivity to HepG-2, HCT-116 and MCF-7 cancer cell lines in vitro, and its IC50 values to tumor cells are 1.78, 1.94 and 3.07, respectively μ M. It showed that it had obvious cytotoxicity.
loading...
    loading...
Cat. No.: HY-146252
CAS No.: 2414601-79-7
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

hCAXII-IN-4 (compound 5j) is a potent and selective CA XII inhibitor with an Ki value of 6.4 nM for human CA XII .
loading...
    loading...
Cat. No.: HY-179271
Target:  

Carbonic Anhydrase HDAC

Research Areas:  

Cancer

CA/HDAC-IN-1 (Compound 11) is a CA and HDAC inhibitor with Ki values of 7.4 nM, 31.0 nM, and 7.3 nM for hCA II, hCA IX, and hCA XII, respectively, and IC50 values of 0.21 μM and 3.60 μM for HDAC3 and HDAC8, respectively. CA/HDAC-IN-1 has anti-cancer activity against colon cancer, breast cancer, and melanoma .
loading...
    loading...
Cat. No.: HY-150570
CAS No.: 2410402-75-2
Target:  

Carbonic Anhydrase CDK

Research Areas:  

Cancer

Carbonic anhydrase inhibitor 14 (Compound 8b) is a carbonic anhydrase (CA) inhibitor with Ki values of 1203, 99.7, 9.4 and 27.7 nM against hCA I, hCA II, hCA IX and hCA XII, respectively. Carbonic anhydrase inhibitor 14 can also inhibit CDK2 with an IC50 of 20.3 μM. Carbonic anhydrase inhibitor 14 shows antitumor activity .
loading...
    loading...
Cat. No.: HY-175021
HDAC-IN-91 is a multiple inhibitor of HDAC (IC50 = 134.22 nM for HDAC1, 66.29 nM for HDAC2), carbonic anhydrase (CA) (Ki = 72.03 nM for CA IX, 50.76 nM for XII), and tubulin polymerization ( IC50 = 2.56 μM). HDAC-IN-91 inhibits PARP1 and increases the Bax/Bcl-2 ratio. HDAC-IN-91 blocks the cell cycle at the G2/M phase and induces apoptosis through a mitochondrial apoptosis activation mechanism. HDAC-IN-91 can exert potent cytotoxic activity through tubulin polymerization inhibition. HDAC-IN-91 can be used in breast, colorectal, cervical and lung cancer research .
loading...
    loading...
Cat. No.: HY-173194
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

Carbonic anhydrase inhibitor 29 (Compound 5d) is an inhibitor targeting carbonic anhydrase IX (CA IX) and XII (CA XII), with inhibition constants (Ki) of 26.6 nM for CA IX and 10.9 nM for CA XII. Carbonic anhydrase inhibitor 29 can be used in anticancer research .
loading...
    loading...
Cat. No.: HY-151472
CAS No.: 3031666-31-3
Target:  

Carbonic Anhydrase

Research Areas:  

Infection

hCAIX/XII-IN-6 is an orally active carbonic anhydrase (CA) inhibitor. hCAIX/XII-IN-6 inhibits human CA isoforms hCA I, II, IV, IX, and XII with Ki values of 6697 nM, 2950 nM, 4093 nM, 4.1 nM and 7.7 nM, respectively. hCAIX/XII-IN-6 can be used for the research of rheumatoid arthritis (RA) .
loading...
    loading...
Cat. No.: HY-172950
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

CAXII-IN-2 (compound 3j) is a potent CAXII inhibitor. CAXII-IN-2 inhibits CA IX and CAXII with Ki of 27.4 and 4.0 nM, respectively .
loading...
    loading...
Cat. No.: HY-146259
CAS No.: 1119200-33-7
Target:  

Carbonic Anhydrase

Research Areas:  

Others

hCAIX/XII-IN-4 (compound 6c) is a potent CAIX/XII inhibitor with the Ki values of 4.5 nM, 23.6 nM, >10000 nM and >10000 nM for CAXII, CAIX, CAI and CAⅡ, respectively .
loading...
    loading...
Cat. No.: HY-143460
CAS No.: 2479918-59-5
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

CAXII-IN-1 (Compound 17) is a selective CA XII inhibitor with Ki values of 3.8 nM and 56.0 nM against hCA XII and hCA IX, respectively. CAXII-IN-1 shows antitumor activity .
loading...
    loading...
Cat. No.: HY-150695
CAS No.: 2421127-99-1
Research Areas:  

Cancer

hCAIX/XII-IN-5 (Coumarin 9a) a carbonic anhydrase (CA) inhibitor, and exhibits excellent hCA IX/XII selectivity (Ki=93.9 and 85.7 nM, respectively) over hCA I and hCA II. hCAIX/XII-IN-5 shows anti-proliferative activities to cancer cells. hCAIX/XII-IN-5 can delay cell cycle and induce apoptosis .
loading...
    loading...
Cat. No.: HY-162063
Target:  

Carbonic Anhydrase

Research Areas:  

Inflammation/Immunology Cancer

hCAIX/XII-IN-9 (compound 8) is a potent carbonic anhydrase (CA) inhibitor with Ki values of 1658 nM, 184.8 nM, 8.9 nM, 64.8 nM for hCA I, hCA II, hCA IX, and hCA XII, respectively .
loading...
    loading...
Cat. No.: HY-156181
CAS No.: 59994-64-8
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

hCAIX/XII-IN-8 (compound 3g) is a potent human (carbonic anhydrase) CA IX and XII inhibitor, with Ki values of 8.5 and 6.7 nM, respectively. hCAIX/XII-IN-8 shows particularly strong inhibitory activity against the tumor-associated membrane-bound isoforms, hCA IX and XII, while maintaining a high selectivity ratio over cytosolic off-target isoforms hCA I and II .
loading...
    loading...
Cat. No.: HY-178030
CAXII-IN-3 is an effective carbonic anhydrase (CA XII) inhibitor with a Ki of 53 nM. CAXII-IN-3 exhibits selective inhibition against multiple human CA subtypes with Kis of 5.3 μM, 75 nM, 1.9 μM, > 10 μM against CA I, CA II, CA IV and CA IX. CAXII-IN-3 mainly inhibits CA II and XII, and reduces aqueous humor production. CAXII-IN-3 exhibits β3-AR agonistic activity, can dilate retinal blood vessels, and improve optic nerve perfusion. CAXII-IN-3 can be used in the research of ocular disorders such as glaucoma .
loading...
    loading...
Cat. No.: HY-162000
Target:  

Apoptosis

Research Areas:  

Cancer

hCAIX/XII-IN-13 is an inhibitor of human carbonic anhydrases (hCA). hCAIX/XII-IN-13 shows good inhibitory activity against the tumor-related CA subtypes IX and XII, with Ki values of 0.08 µM and 0.06 µM, respectively. Under hypoxic conditions, hCAIX/XII-IN-13 can restore the cytotoxicity of Doxorubicin (HY-15142A) on MCF-7 cells, increasing G2/M phase cell cycle arrest and apoptosis .
loading...
    loading...